emerging subcutaneous infusions for pd: efficacy & infusion site reactions
Published 1 year ago • 755 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
1:29
benefits and challenges associated with subcutaneous infusions for parkinson’s disease
-
3:02
subcutaneous 24-hour infusion of foslevodopa/foscarbidopa improves motor symptoms in pd patients
-
0:51
how can continuous dopaminergic delivery improve outcomes in pd?
-
0:50
subcutaneous levodopa/carbidopa infusion for parkinson's disease
-
1:27
updates on levodopa infusion therapies for advanced parkinson’s disease
-
3:02
improvements to levodopa-based treatments for parkinson’s disease
-
1:06
upcoming advancements in subcutaneous levodopa therapy for pd
-
35:50
what's new in parkinson's research - uf pd educational symposium 2024
-
1:20
managing skin complications from pd treatment
-
18:15
long-acting, subcutaneous levodopa in parkinson's disease: is it safe?
-
1:18
interim results of sc foslevodopa/foscarbidopa in parkinson’s disease
-
1:33
final results of duoglobe: real-world evidence for lgic in advanced parkinson’s disease
-
2:18
clinic vs home dose optimisation of apomorphine sublingual film in parkinson’s disease
-
0:59
early identification of suboptimal pd control to improve care
-
0:31
um school of medicine develops non-invasive treatment for parkinson's disease
-
51:54
emerging therapies for parkinson's: levodopa edition
-
7:59
continous subcutaneous apomorphine infusion - indian experience
-
1:20
foslevodopa/foscarbidopa improves nocturia symptoms in patients with parkinson’s disease